Global Glycan Analysis Market

Glycan Analysis Comprehensive Study by Analysis (Mass Spectrometry (MS), High-Performance Liquid Chromatography (HPLC), Capillary Electrophoresis (CE), Isoelectric Focusing (IEF) Polyacrylamide Gel (PAGE) Electrophoresis), End-User (Research Institutes, Biopharmaceutical Companies, CROs, CMOs) Players and Region - Global Market Outlook to 2030

Glycan Analysis Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 20.8%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Glycan Analysis Market Overview:
Glycans are carbohydrate-based polymers made by all living organisms. Glycans are also called polysaccharides. These are essential biomolecules serving structure, energy storage and system regulatory purposes. Many biopharmaceuticals are glycosylated proteins produced by living cell systems includes monoclonal antibodies and other recombinant protein products. Protein glycosylation increases protein stability in vitro and protects protein from proteolytic degradation. As per latest study released by AMA Research, the Global Glycan Analysis market is expected to see growth rate of 20.8%

AttributesDetails
Study Period2018-2030
Base Year2023
Forecast Period2024-2030
Historical Period2018-2023
UnitValue (USD Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Influencing Trend:
Technological Development and Innovations in Healthcare

Market Growth Drivers:
Increasing Use of Biopharmaceutical Products, Rising Prevalence of Cancer, Autoimmune Diseases or Other Life-Threatening Diseases and Increasing Government Funding for Research and Development Activities

Challenges:
Complexity of Protein Glycosylation

Restraints:
Huge Initial Investment for Research and Development Activities

Opportunities:
Growing Pharmaceutical Industry Worldwide and Increasing Research and Development Investment by Major Players

Competitive Landscape:
The market is seeing moderate market players, by seeing huge growth in this market the key leading vendors are highly focusing on production technologies, efficiency enhancement, and product life. This market has various growth opportunities that leading players capture via tracking the ongoing process enhancement and huge investment in market growth strategies.
Some of the key players profiled in the report are Sartorius Stedim BioOutsource (Germany), ProZyme (United States), S-Bio (United States), Thermo Fisher Scientific (United States), Waters Corp (United States) and Agilent Technologies (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Glycan Analysis market by 2030. Considering Market by Analysis, the sub-segment i.e. Mass Spectrometry (MS) will boost the Glycan Analysis market. Considering Market by End-User, the sub-segment i.e. Research Institutes will boost the Glycan Analysis market.

Latest Market Insights:
In February 2023, Bruker Corporation announced a collaboration with the National Cancer Institute (NCI) to develop new glycan analysis technologies for cancer research.

In October 2023, Glycosyn launched the GlycoWorks Enzymatic Release Kit for N-linked Glycans, offering a simplified and efficient method for releasing N-glycans from glycoproteins.

What Can be Explored with the Glycan Analysis Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Glycan Analysis Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Glycan Analysis
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Glycan Analysis market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Glycan Analysis market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Glycan Analysis Providers, Emerging Companies, Research Institutes, Government Body & Associations and End-user.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Analysis
  • Mass Spectrometry (MS)
  • High-Performance Liquid Chromatography (HPLC)
  • Capillary Electrophoresis (CE)
  • Isoelectric Focusing (IEF) Polyacrylamide Gel (PAGE) Electrophoresis

By End-User
  • Research Institutes
  • Biopharmaceutical Companies
  • CROs
  • CMOs

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Use of Biopharmaceutical Products
      • 3.2.2. Rising Prevalence of Cancer, Autoimmune Diseases or Other Life-Threatening Diseases
      • 3.2.3. Increasing Government Funding for Research and Development Activities
    • 3.3. Market Challenges
      • 3.3.1. Complexity of Protein Glycosylation
    • 3.4. Market Trends
      • 3.4.1. Technological Development and Innovations in Healthcare
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Glycan Analysis, by Analysis, End-User and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Glycan Analysis (Value)
      • 5.2.1. Global Glycan Analysis by: Analysis (Value)
        • 5.2.1.1. Mass Spectrometry (MS)
        • 5.2.1.2. High-Performance Liquid Chromatography (HPLC)
        • 5.2.1.3. Capillary Electrophoresis (CE)
        • 5.2.1.4. Isoelectric Focusing (IEF) Polyacrylamide Gel (PAGE) Electrophoresis
      • 5.2.2. Global Glycan Analysis by: End-User (Value)
        • 5.2.2.1. Research Institutes
        • 5.2.2.2. Biopharmaceutical Companies
        • 5.2.2.3. CROs
        • 5.2.2.4. CMOs
      • 5.2.3. Global Glycan Analysis Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Glycan Analysis: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Sartorius Stedim BioOutsource (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. ProZyme (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. S-Bio (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Thermo Fisher Scientific (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Waters Corp (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Agilent Technologies (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
  • 7. Global Glycan Analysis Sale, by Analysis, End-User and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Glycan Analysis (Value)
      • 7.2.1. Global Glycan Analysis by: Analysis (Value)
        • 7.2.1.1. Mass Spectrometry (MS)
        • 7.2.1.2. High-Performance Liquid Chromatography (HPLC)
        • 7.2.1.3. Capillary Electrophoresis (CE)
        • 7.2.1.4. Isoelectric Focusing (IEF) Polyacrylamide Gel (PAGE) Electrophoresis
      • 7.2.2. Global Glycan Analysis by: End-User (Value)
        • 7.2.2.1. Research Institutes
        • 7.2.2.2. Biopharmaceutical Companies
        • 7.2.2.3. CROs
        • 7.2.2.4. CMOs
      • 7.2.3. Global Glycan Analysis Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Glycan Analysis: by Analysis(USD Million)
  • Table 2. Glycan Analysis Mass Spectrometry (MS) , by Region USD Million (2018-2023)
  • Table 3. Glycan Analysis High-Performance Liquid Chromatography (HPLC) , by Region USD Million (2018-2023)
  • Table 4. Glycan Analysis Capillary Electrophoresis (CE) , by Region USD Million (2018-2023)
  • Table 5. Glycan Analysis Isoelectric Focusing (IEF) Polyacrylamide Gel (PAGE) Electrophoresis , by Region USD Million (2018-2023)
  • Table 6. Glycan Analysis: by End-User(USD Million)
  • Table 7. Glycan Analysis Research Institutes , by Region USD Million (2018-2023)
  • Table 8. Glycan Analysis Biopharmaceutical Companies , by Region USD Million (2018-2023)
  • Table 9. Glycan Analysis CROs , by Region USD Million (2018-2023)
  • Table 10. Glycan Analysis CMOs , by Region USD Million (2018-2023)
  • Table 11. South America Glycan Analysis, by Country USD Million (2018-2023)
  • Table 12. South America Glycan Analysis, by Analysis USD Million (2018-2023)
  • Table 13. South America Glycan Analysis, by End-User USD Million (2018-2023)
  • Table 14. Brazil Glycan Analysis, by Analysis USD Million (2018-2023)
  • Table 15. Brazil Glycan Analysis, by End-User USD Million (2018-2023)
  • Table 16. Argentina Glycan Analysis, by Analysis USD Million (2018-2023)
  • Table 17. Argentina Glycan Analysis, by End-User USD Million (2018-2023)
  • Table 18. Rest of South America Glycan Analysis, by Analysis USD Million (2018-2023)
  • Table 19. Rest of South America Glycan Analysis, by End-User USD Million (2018-2023)
  • Table 20. Asia Pacific Glycan Analysis, by Country USD Million (2018-2023)
  • Table 21. Asia Pacific Glycan Analysis, by Analysis USD Million (2018-2023)
  • Table 22. Asia Pacific Glycan Analysis, by End-User USD Million (2018-2023)
  • Table 23. China Glycan Analysis, by Analysis USD Million (2018-2023)
  • Table 24. China Glycan Analysis, by End-User USD Million (2018-2023)
  • Table 25. Japan Glycan Analysis, by Analysis USD Million (2018-2023)
  • Table 26. Japan Glycan Analysis, by End-User USD Million (2018-2023)
  • Table 27. India Glycan Analysis, by Analysis USD Million (2018-2023)
  • Table 28. India Glycan Analysis, by End-User USD Million (2018-2023)
  • Table 29. South Korea Glycan Analysis, by Analysis USD Million (2018-2023)
  • Table 30. South Korea Glycan Analysis, by End-User USD Million (2018-2023)
  • Table 31. Taiwan Glycan Analysis, by Analysis USD Million (2018-2023)
  • Table 32. Taiwan Glycan Analysis, by End-User USD Million (2018-2023)
  • Table 33. Australia Glycan Analysis, by Analysis USD Million (2018-2023)
  • Table 34. Australia Glycan Analysis, by End-User USD Million (2018-2023)
  • Table 35. Rest of Asia-Pacific Glycan Analysis, by Analysis USD Million (2018-2023)
  • Table 36. Rest of Asia-Pacific Glycan Analysis, by End-User USD Million (2018-2023)
  • Table 37. Europe Glycan Analysis, by Country USD Million (2018-2023)
  • Table 38. Europe Glycan Analysis, by Analysis USD Million (2018-2023)
  • Table 39. Europe Glycan Analysis, by End-User USD Million (2018-2023)
  • Table 40. Germany Glycan Analysis, by Analysis USD Million (2018-2023)
  • Table 41. Germany Glycan Analysis, by End-User USD Million (2018-2023)
  • Table 42. France Glycan Analysis, by Analysis USD Million (2018-2023)
  • Table 43. France Glycan Analysis, by End-User USD Million (2018-2023)
  • Table 44. Italy Glycan Analysis, by Analysis USD Million (2018-2023)
  • Table 45. Italy Glycan Analysis, by End-User USD Million (2018-2023)
  • Table 46. United Kingdom Glycan Analysis, by Analysis USD Million (2018-2023)
  • Table 47. United Kingdom Glycan Analysis, by End-User USD Million (2018-2023)
  • Table 48. Netherlands Glycan Analysis, by Analysis USD Million (2018-2023)
  • Table 49. Netherlands Glycan Analysis, by End-User USD Million (2018-2023)
  • Table 50. Rest of Europe Glycan Analysis, by Analysis USD Million (2018-2023)
  • Table 51. Rest of Europe Glycan Analysis, by End-User USD Million (2018-2023)
  • Table 52. MEA Glycan Analysis, by Country USD Million (2018-2023)
  • Table 53. MEA Glycan Analysis, by Analysis USD Million (2018-2023)
  • Table 54. MEA Glycan Analysis, by End-User USD Million (2018-2023)
  • Table 55. Middle East Glycan Analysis, by Analysis USD Million (2018-2023)
  • Table 56. Middle East Glycan Analysis, by End-User USD Million (2018-2023)
  • Table 57. Africa Glycan Analysis, by Analysis USD Million (2018-2023)
  • Table 58. Africa Glycan Analysis, by End-User USD Million (2018-2023)
  • Table 59. North America Glycan Analysis, by Country USD Million (2018-2023)
  • Table 60. North America Glycan Analysis, by Analysis USD Million (2018-2023)
  • Table 61. North America Glycan Analysis, by End-User USD Million (2018-2023)
  • Table 62. United States Glycan Analysis, by Analysis USD Million (2018-2023)
  • Table 63. United States Glycan Analysis, by End-User USD Million (2018-2023)
  • Table 64. Canada Glycan Analysis, by Analysis USD Million (2018-2023)
  • Table 65. Canada Glycan Analysis, by End-User USD Million (2018-2023)
  • Table 66. Mexico Glycan Analysis, by Analysis USD Million (2018-2023)
  • Table 67. Mexico Glycan Analysis, by End-User USD Million (2018-2023)
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Glycan Analysis: by Analysis(USD Million)
  • Table 75. Glycan Analysis Mass Spectrometry (MS) , by Region USD Million (2025-2030)
  • Table 76. Glycan Analysis High-Performance Liquid Chromatography (HPLC) , by Region USD Million (2025-2030)
  • Table 77. Glycan Analysis Capillary Electrophoresis (CE) , by Region USD Million (2025-2030)
  • Table 78. Glycan Analysis Isoelectric Focusing (IEF) Polyacrylamide Gel (PAGE) Electrophoresis , by Region USD Million (2025-2030)
  • Table 79. Glycan Analysis: by End-User(USD Million)
  • Table 80. Glycan Analysis Research Institutes , by Region USD Million (2025-2030)
  • Table 81. Glycan Analysis Biopharmaceutical Companies , by Region USD Million (2025-2030)
  • Table 82. Glycan Analysis CROs , by Region USD Million (2025-2030)
  • Table 83. Glycan Analysis CMOs , by Region USD Million (2025-2030)
  • Table 84. South America Glycan Analysis, by Country USD Million (2025-2030)
  • Table 85. South America Glycan Analysis, by Analysis USD Million (2025-2030)
  • Table 86. South America Glycan Analysis, by End-User USD Million (2025-2030)
  • Table 87. Brazil Glycan Analysis, by Analysis USD Million (2025-2030)
  • Table 88. Brazil Glycan Analysis, by End-User USD Million (2025-2030)
  • Table 89. Argentina Glycan Analysis, by Analysis USD Million (2025-2030)
  • Table 90. Argentina Glycan Analysis, by End-User USD Million (2025-2030)
  • Table 91. Rest of South America Glycan Analysis, by Analysis USD Million (2025-2030)
  • Table 92. Rest of South America Glycan Analysis, by End-User USD Million (2025-2030)
  • Table 93. Asia Pacific Glycan Analysis, by Country USD Million (2025-2030)
  • Table 94. Asia Pacific Glycan Analysis, by Analysis USD Million (2025-2030)
  • Table 95. Asia Pacific Glycan Analysis, by End-User USD Million (2025-2030)
  • Table 96. China Glycan Analysis, by Analysis USD Million (2025-2030)
  • Table 97. China Glycan Analysis, by End-User USD Million (2025-2030)
  • Table 98. Japan Glycan Analysis, by Analysis USD Million (2025-2030)
  • Table 99. Japan Glycan Analysis, by End-User USD Million (2025-2030)
  • Table 100. India Glycan Analysis, by Analysis USD Million (2025-2030)
  • Table 101. India Glycan Analysis, by End-User USD Million (2025-2030)
  • Table 102. South Korea Glycan Analysis, by Analysis USD Million (2025-2030)
  • Table 103. South Korea Glycan Analysis, by End-User USD Million (2025-2030)
  • Table 104. Taiwan Glycan Analysis, by Analysis USD Million (2025-2030)
  • Table 105. Taiwan Glycan Analysis, by End-User USD Million (2025-2030)
  • Table 106. Australia Glycan Analysis, by Analysis USD Million (2025-2030)
  • Table 107. Australia Glycan Analysis, by End-User USD Million (2025-2030)
  • Table 108. Rest of Asia-Pacific Glycan Analysis, by Analysis USD Million (2025-2030)
  • Table 109. Rest of Asia-Pacific Glycan Analysis, by End-User USD Million (2025-2030)
  • Table 110. Europe Glycan Analysis, by Country USD Million (2025-2030)
  • Table 111. Europe Glycan Analysis, by Analysis USD Million (2025-2030)
  • Table 112. Europe Glycan Analysis, by End-User USD Million (2025-2030)
  • Table 113. Germany Glycan Analysis, by Analysis USD Million (2025-2030)
  • Table 114. Germany Glycan Analysis, by End-User USD Million (2025-2030)
  • Table 115. France Glycan Analysis, by Analysis USD Million (2025-2030)
  • Table 116. France Glycan Analysis, by End-User USD Million (2025-2030)
  • Table 117. Italy Glycan Analysis, by Analysis USD Million (2025-2030)
  • Table 118. Italy Glycan Analysis, by End-User USD Million (2025-2030)
  • Table 119. United Kingdom Glycan Analysis, by Analysis USD Million (2025-2030)
  • Table 120. United Kingdom Glycan Analysis, by End-User USD Million (2025-2030)
  • Table 121. Netherlands Glycan Analysis, by Analysis USD Million (2025-2030)
  • Table 122. Netherlands Glycan Analysis, by End-User USD Million (2025-2030)
  • Table 123. Rest of Europe Glycan Analysis, by Analysis USD Million (2025-2030)
  • Table 124. Rest of Europe Glycan Analysis, by End-User USD Million (2025-2030)
  • Table 125. MEA Glycan Analysis, by Country USD Million (2025-2030)
  • Table 126. MEA Glycan Analysis, by Analysis USD Million (2025-2030)
  • Table 127. MEA Glycan Analysis, by End-User USD Million (2025-2030)
  • Table 128. Middle East Glycan Analysis, by Analysis USD Million (2025-2030)
  • Table 129. Middle East Glycan Analysis, by End-User USD Million (2025-2030)
  • Table 130. Africa Glycan Analysis, by Analysis USD Million (2025-2030)
  • Table 131. Africa Glycan Analysis, by End-User USD Million (2025-2030)
  • Table 132. North America Glycan Analysis, by Country USD Million (2025-2030)
  • Table 133. North America Glycan Analysis, by Analysis USD Million (2025-2030)
  • Table 134. North America Glycan Analysis, by End-User USD Million (2025-2030)
  • Table 135. United States Glycan Analysis, by Analysis USD Million (2025-2030)
  • Table 136. United States Glycan Analysis, by End-User USD Million (2025-2030)
  • Table 137. Canada Glycan Analysis, by Analysis USD Million (2025-2030)
  • Table 138. Canada Glycan Analysis, by End-User USD Million (2025-2030)
  • Table 139. Mexico Glycan Analysis, by Analysis USD Million (2025-2030)
  • Table 140. Mexico Glycan Analysis, by End-User USD Million (2025-2030)
  • Table 141. Research Programs/Design for This Report
  • Table 142. Key Data Information from Secondary Sources
  • Table 143. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Glycan Analysis: by Analysis USD Million (2018-2023)
  • Figure 5. Global Glycan Analysis: by End-User USD Million (2018-2023)
  • Figure 6. South America Glycan Analysis Share (%), by Country
  • Figure 7. Asia Pacific Glycan Analysis Share (%), by Country
  • Figure 8. Europe Glycan Analysis Share (%), by Country
  • Figure 9. MEA Glycan Analysis Share (%), by Country
  • Figure 10. North America Glycan Analysis Share (%), by Country
  • Figure 11. Global Glycan Analysis share by Players 2023 (%)
  • Figure 12. Global Glycan Analysis share by Players (Top 3) 2023(%)
  • Figure 13. BCG Matrix for key Companies
  • Figure 14. Sartorius Stedim BioOutsource (Germany) Revenue, Net Income and Gross profit
  • Figure 15. Sartorius Stedim BioOutsource (Germany) Revenue: by Geography 2023
  • Figure 16. ProZyme (United States) Revenue, Net Income and Gross profit
  • Figure 17. ProZyme (United States) Revenue: by Geography 2023
  • Figure 18. S-Bio (United States) Revenue, Net Income and Gross profit
  • Figure 19. S-Bio (United States) Revenue: by Geography 2023
  • Figure 20. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 21. Thermo Fisher Scientific (United States) Revenue: by Geography 2023
  • Figure 22. Waters Corp (United States) Revenue, Net Income and Gross profit
  • Figure 23. Waters Corp (United States) Revenue: by Geography 2023
  • Figure 24. Agilent Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 25. Agilent Technologies (United States) Revenue: by Geography 2023
  • Figure 26. Global Glycan Analysis: by Analysis USD Million (2025-2030)
  • Figure 27. Global Glycan Analysis: by End-User USD Million (2025-2030)
  • Figure 28. South America Glycan Analysis Share (%), by Country
  • Figure 29. Asia Pacific Glycan Analysis Share (%), by Country
  • Figure 30. Europe Glycan Analysis Share (%), by Country
  • Figure 31. MEA Glycan Analysis Share (%), by Country
  • Figure 32. North America Glycan Analysis Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Sartorius Stedim BioOutsource (Germany)
  • ProZyme (United States)
  • S-Bio (United States)
  • Thermo Fisher Scientific (United States)
  • Waters Corp (United States)
  • Agilent Technologies (United States)
Select User Access Type

Key Highlights of Report


Feb 2024 268 Pages 53 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Glycan Analysis Market Quantitative research analysis
Global Glycan Analysis Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Glycan Analysis market are Sartorius Stedim BioOutsource (Germany), ProZyme (United States), S-Bio (United States), Thermo Fisher Scientific (United States), Waters Corp (United States) and Agilent Technologies (United States), to name a few.
"Technological Development and Innovations in Healthcare" is seen as one of major influencing trends for Glycan Analysis Market during projected period 2023-2030.

Know More About Global Glycan Analysis Market Report?

Have a Query? Click Here

Other Related Reports

Biomedical Nanotechnology Comprehensive Study by Application (Diagnostics, Sensing, Drugs, Prostheses and Implants, Others), Product (Treatment, Nanomedicine (Nanosensors), Agricultural Technology, G...
$ 3450
Biofermin Comprehensive Study by Type (Tablets, Powdery, Other), Application (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Players and Region - Global Market Outlook to 2026
$ 3500
Gallnuts Acid Comprehensive Study by Type (Industrial Grade, Pharmaceutical Grade, Food Grade), Application (Antioxidants, Biological Activity, Medical applications, Other), Extract (Gallnuts, Sumac,...
$ 3350
Soft Tissue Allograft Comprehensive Study by Type (Cartilage Allografts, Tendon Allografts, Meniscus Allografts, Dental Allografts, Collagen Allografts, Amniotic Allografts), Application (Orthopedic,...
$ 3650
Biological Control Comprehensive Study by Type (Predatory Mites, Insects, Nematodes, Other), Application (Seed Treatment, Post-Harvest, On-Field), Crop (Vegetables, Fruit, Pulses & Oils, Cereals & Gr...
$ 3450
Pet Clones Comprehensive Study by Type (Cloned Cats, Cloned Dogs, Cloned Horse, Others), Application (Public Welfare, Commercial), Methods (Donor Cell Preparation, Oocyte collection and somatic cell ...
$ 3450